| Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials AY Dawed, A Mari, A Brown, TJ McDonald, L Li, S Wang, MG Hong, ... The Lancet Diabetes & Endocrinology 11 (1), 33-41, 2023 | 40 | 2023 |
| Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration HR Wilman, CA Parisinos, N Atabaki-Pasdar, M Kelly, EL Thomas, ... Journal of Hepatology 71 (3), 594-602, 2019 | 29 | 2019 |
| Alternative treatment regimens with the PCSK9 inhibitors alirocumab and evolocumab: a pharmacokinetic and pharmacodynamic modeling approach N Scherer, C Dings, M Böhm, U Laufs, T Lehr The Journal of Clinical Pharmacology 57 (7), 846-854, 2017 | 15 | 2017 |
| Significant impact of time-of-day variation on metformin pharmacokinetics D Türk, N Scherer, D Selzer, C Dings, N Hanke, R Dallmann, M Schwab, ... Diabetologia 66 (6), 1024-1034, 2023 | 10 | 2023 |
| Pharmacometric modeling of the impact of azelastine nasal spray on SARS-CoV-2 viral load and related symptoms in COVID-19 patients C Dings, P Meiser, F Holzer, M Flegel, D Selzer, E Nagy, R Mösges, ... Pharmaceutics 14 (10), 2059, 2022 | 7 | 2022 |
| Model-based analysis of SARS-CoV-2 infections, hospitalization and outcome in Germany, the Federal States and districts C Dings, KM Götz, K Och, I Sihinevich, Q Werthner, S Smola, M Bliem, ... Viruses 14 (10), 2114, 2022 | 7 | 2022 |
| The Impact and Correction of Analysis Delay and Variability in Storage Temperature on the Assessment of HbA1c from Dried Blood Spots-an IMI DIRECT Study N Scherer, A Kurbasic, C Dings, A Mari, V Nock, AM Hennige, RW Koivula, ... Int J Proteom Bioinf 4, 7-13, 2019 | 4 | 2019 |
| Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo … P Sager, A Kaiser, S Schumann, B Ludescher, M Niedermaier, I Schmidt, ... The Lancet Regional Health–Europe 37, 2024 | 2 | 2024 |
| Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts. Viruses 2022, 14, 2114 C Dings, KM Götz, K Och, I Sihinevich, Q Werthner, S Smola, M Bliem, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Population kinetic/pharmacodynamic modelling of the haemodynamic effects of cafedrine/theodrenaline (Akrinor) under general anaesthesia C Dings, T Lehr, B Vojnar, C Gaik, T Koch, LHJ Eberhart, ... British Journal of Clinical Pharmacology, 2024 | | 2024 |
| Motivations for Adolescent COVID-19 Vaccination: A Comparative Study of Adolescent and Caregiver Perspectives in Germany T Rothoeft, F Brinkmann, C Maier, D Selzer, C Dings, A Kuehn, E Möhler, ... Children 10 (12), 1890, 2023 | | 2023 |
| Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics 2022, 14, 2059 C Dings, P Meiser, F Holzer, M Flegel, D Selzer, E Nagy, R Mösges, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Mathematical modelling of glucose tolerance tests describing glucose, insulin and C-peptide levels in different cohorts: an IMI DIRECT study C Dings, N Scherer, V Nock, AM Hennige, ER Pearson, PW Franks, ... DIABETOLOGIA 61, S144-S144, 2018 | | 2018 |
| Pharmacokinetic And Dynamic Interaction Of Propofol And Sufentanil S Kreuer, C Dings, T Hüppe, K Bröker, T Volk, F Maurer | | |
